-->
Clinical workflow solutions market was valued at US$ 13.61 billion in 2024 and is projected to hit the market valuation of US$ 40.24 billion by 2033 at a CAGR of 12.8% during the forecast period 2025–2033.
Autologous cell therapy market was valued at US$ 10.12 billion in 2024 and is projected to hit the market valuation of US$ 44.55 billion by 2033 at a CAGR of 17.90% during the forecast period 2025–2033.
Cancer gene therapy market was valued at US$ 3.89 billion in 2024 and is projected to hit the market valuation of US$ 17.57 billion by 2033 at a CAGR of 18.24% during the forecast period 2025–2033.
The Herbal Medicine market is projected to grow significantly, with revenues rising from USD 205.2 billion in 2024 to USD 533.6 billion by 2033, marking a robust CAGR of 11.3% throughout the forecast period 2025-2033.
The global oral vaccines market is set to experience significant growth, with revenue projected to rise from USD 3,985.9 million in 2024 to USD 8,800 million by 2033, reflecting a strong compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2033.